Aballa, Jane Eilyza G. Jan.

7 2020
CHE 507

Nintendo Loses Patent

Lawsuit, Ordered to Pay $10
Million
A jury sided with medical device company iLife that claimed the
Nintendo Wii uses its patented technology

Last week, a small company based in Texas won its patent infringement lawsuit against Nintendo
of America. The jury awarded iLife Technologies $10 million in damages when it decided that
Nintendo's Wii controllers infringe on iLife's six patents on motion-sensing technology.
iLife filed the federal patent lawsuit against Nintendo in 2013, asking for $144 million. The suit
stated that Nintendo's Wii and Wii U controllers use accelerometers to track how a player is
moving their hands relative to their environment, which is a system iLife says it invented and
patented for use in medical monitors that would automatically call an ambulance if an elderly
person fell or if a baby was at risk of dying from sudden infant death syndrome.
Nintendo, in a statement during the court proceeding, said the patent was not written correctly to
cover the way the company used motion-sensing technology in its controllers. In a statement to
the BBC, the company said it would appeal the judgment.
"Nintendo disagrees with the decision, as Nintendo does not infringe iLife's patent and the patent
is invalid," Nintendo said in a statement. "Nintendo looks forward to raising those issues with the
district court and with the court of appeals."
iLife's lawsuit sought a $4 royalty on each Wii console sold in the six years before iLife launched
legal action, totaling 36 million units. iLife also sued Fitbit and Under Armour in similar lawsuits,
both of which were dismissed and settled out of court, according to court filings.
Back in 2013, an attorney for iLife's CEO Michael Lehrman denounced claims that Lehrman was
a "patent troll."
"iLife and its CEO Michael Lehrman are the original inventors of this technology, and the company
does not enforce any patents that it did not develop," Wallace Dunwoody, an attorney and partner
at Munck Wilson Mandala, told the Dallas Observer. "Unlike so-called patent trolls, iLife also has
a history of developing and bringing to market products using their

Reference: https://www.inc.com/will-yakowicz/nintendo-loses-patent-infringement-case-wii.html
Calara, Kim Carlo Jan. 7 2020
CHE 507

Sun Pharma's subsidiary files patent

infringement suit against German drug
maker Biofrontera
DUSA has alleged that Biofrontera defendants misappropriated confidential and trade
secret information from DUSA and improperly obtained confidential DUSA information
from its former employees to sell and market their own products.
Sun Pharma's US subsidiary DUSA pharmaceuticals on Wednesday said that the company has filed a law suit against
German drug maker Biofrontera for patent infringement, trade secret misappropriation and tortious interference claims
in an on going patent infringement suit.

DUSA has alleged that Biofrontera defendants misappropriated confidential and trade secret information from DUSA
and improperly obtained confidential DUSA information from its former employees to sell and market their own products.

At the heart of the contention are two drugs of DUSA- LEVULAN® KERASTICK® (aminolevulinic acid HCl) for topical
solution. "The lawsuit seeks an assessment of both damages and injunctive relief against the Biofrontera defendants",
Sun PharmaNSE 0.83 % said in a statement. The company added that the patents-in-suit deals with an apparatus and
method for “photodynamic therapy” (or “PDT”) and equipment for PDT. According to DUSA's claims the photodynamic
therapy, pioneered by DUSA, combines a drug with a light source to treat disease conditions.

The product was launched by DUSA in September 2000 in the US.

Reference: https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/sun-pharmas-
subsidiary-files-patent-infringement-suit-against-german-drug-maker-biofrontera/articleshow/64949745.cms